Allied Market Research

2026

Monoclonal Antibody Market

Monoclonal Antibody Market (2023-2032)

by Source (Murine, Chimeric, Humanized, Human), by Production (In Vivo, In Vitro), by Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others) and, by End User (Hospitals, Research Institutes, Others)

LS : Pharmaceuticals

Select an option
Author's: |
Publish Date: